Literature DB >> 33396406

zzm321990 ERG3-Encoding Sterol C5,6-DESATURASE in Candida albicans Is Required for Virulence in an Enterically Infected Invasive Candidiasis Mouse Model.

Tatsuro Hirayama1, Taiga Miyazaki1,2, Makoto Sumiyoshi1, Nobuyuki Ashizawa1, Takahiro Takazono1,2, Kazuko Yamamoto1, Yoshifumi Imamura1, Koichi Izumikawa2, Katsunori Yanagihara3, Shigeru Kohno1, Hiroshi Mukae1.   

Abstract

Gastrointestinal colonization by Candida species is considered the main source of candidemia. The ERG3 gene in Candida albicans encodes a sterol C5,6-desaturase, which is essential for ergosterol biosynthesis. Although ERG3 inactivation shows reduced virulence in mouse models of disseminated candidiasis, the role of ERG3 in intestinal infections is unknown. Here, we infected mice with the C. albicans strains CAE3DU3 and CAF2-1, containing mutant and wild-type ERG3, respectively, and studied gut infection and colonization by these strains. We found that the CAE3DU3 strain showed reduced colonization, pathogenesis, damage to gut mucosa, and chemokine production in the mouse model of invasive candidiasis. Additionally, mice inoculated with CAE3DU3 showed lower mortality than mice inoculated with CAF2-1 (p < 0.0001). Chemokines were less induced in the gut inoculated with CAE3DU3 than in the gut inoculated with CAF2-1. Histopathologically, although the wild-type gene was associated with a higher pathogenicity and invasion of the gut mucosa and liver tissues causing remarkable tissue necrosis, the erg3/erg3 mutant was associated with a higher accumulation of cells and lower damage to surrounding tissues than wild-type ERG3. These results establish that the ergosterol biosynthetic pathway may be associated with C. albicans gut colonization and subsequent dissemination.

Entities:  

Keywords:  Candida albicans; ERG3; colonization; ergosterol; intestinal tract; pathogenesis

Year:  2020        PMID: 33396406      PMCID: PMC7823479          DOI: 10.3390/pathogens10010023

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  22 in total

1.  Revisiting the source of candidemia: skin or gut?

Authors:  M Nucci; E Anaissie
Journal:  Clin Infect Dis       Date:  2001-11-08       Impact factor: 9.079

2.  Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.

Authors:  Florent Morio; Fabrice Pagniez; Claire Lacroix; Michel Miegeville; Patrice Le Pape
Journal:  J Antimicrob Chemother       Date:  2012-06-07       Impact factor: 5.790

3.  Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.

Authors:  Taiga Miyazaki; Yoshitsugu Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Shunichi Miyakoshi; John E Bennett; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 4.  Fungi in the healthy human gastrointestinal tract.

Authors:  Heather E Hallen-Adams; Mallory J Suhr
Journal:  Virulence       Date:  2016-10-13       Impact factor: 5.882

Review 5.  Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

Authors:  Michael Pfaller; Dionissios Neofytos; Daniel Diekema; Nkechi Azie; Herwig-Ulf Meier-Kriesche; Shun-Ping Quan; David Horn
Journal:  Diagn Microbiol Infect Dis       Date:  2012-10-25       Impact factor: 2.803

6.  Candida albicans Morphogenesis Programs Control the Balance between Gut Commensalism and Invasive Infection.

Authors:  Jessica N Witchley; Pallavi Penumetcha; Nina V Abon; Carol A Woolford; Aaron P Mitchell; Suzanne M Noble
Journal:  Cell Host Microbe       Date:  2019-03-13       Impact factor: 21.023

7.  Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.

Authors:  Dominique Sanglard; Françoise Ischer; Tania Parkinson; Derek Falconer; Jacques Bille
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.

Authors:  Arturo Luna-Tapia; Brian M Peters; Karen E Eberle; Morgan E Kerns; Timothy P Foster; Luis Marrero; Mairi C Noverr; Paul L Fidel; Glen E Palmer
Journal:  Eukaryot Cell       Date:  2015-07-31

Review 9.  Invasive candidiasis.

Authors:  Peter G Pappas; Michail S Lionakis; Maiken Cavling Arendrup; Luis Ostrosky-Zeichner; Bart Jan Kullberg
Journal:  Nat Rev Dis Primers       Date:  2018-05-11       Impact factor: 52.329

10.  Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation.

Authors:  Tatsuro Hirayama; Taiga Miyazaki; Yuya Ito; Megumi Wakayama; Kazutoshi Shibuya; Kohei Yamashita; Takahiro Takazono; Tomomi Saijo; Shintaro Shimamura; Kazuko Yamamoto; Yoshifumi Imamura; Koichi Izumikawa; Katsunori Yanagihara; Shigeru Kohno; Hiroshi Mukae
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

View more
  2 in total

1.  Enhancement of the antifungal activity of some antimycotics by farnesol and reduction of Candida albicans pathogenicity in a quail model experiment.

Authors:  Nadezhda Sachivkina; Alexander Senyagin; Irina Podoprigora; Elena Vasilieva; Olga Kuznetsova; Arfenia Karamyan; Alfia Ibragimova; Natalia Zhabo; Maria Molchanova
Journal:  Vet World       Date:  2022-04-08

2.  Reduction in Pathogenicity in Yeast-like Fungi by Farnesol in Quail Model.

Authors:  Nadezhda Sachivkina; Elena Vasilieva; Ekaterina Lenchenko; Olga Kuznetsova; Arfenia Karamyan; Alfia Ibragimova; Natalia Zhabo; Maria Molchanova
Journal:  Animals (Basel)       Date:  2022-02-16       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.